SEC Form 4 · accession 0001203311-15-000009
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vaughn B Himes
Officer — EVP, Proc Svcs & Tech Ops
Period of report
Mar 12, 2015
Accepted (ET)
Mar 16, 2015 · 7:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 12, 2015 | M | 20,000 | $9.23 | A | 87,209 | D | |
| Common StockF2,F1 | Mar 12, 2015 | S | 20,000 | $36.6496 | D | 67,209 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F3 | $9.23 | Mar 12, 2015 | M | 20,000 | D | — | Apr 30, 2019 | Common Stock | 20,000 | 93,664 | D |
Explanation of responses
- F1Amount of securities beneficially owned following the reported transaction(s) include Restricted Stock Units that are subject to vesting.
- F2Sale price represents a weighted average price for all shares sold on this day, which are within a $1.00 range.
- F3Shares shall vest at a rate of 25% on 4/1/10 and monthly thereafter until all the shares are fully vested on 4/1/13.